US Patent 7750037 Antidepressant
Patent 7750037 was granted and assigned to Takeda Pharmaceutical Company on July, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+97 characters)
Article
Patent abstract
A PKB (Akt) activating agent comprising a compound represented by the formula (I):
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07750037 Antidepressant US Patent 7750037 Antidepressant
Infobox
Patent Number
0775003700
Patent Number
775003700
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077500370
Date of Patent
July 6, 2010
0Patent Application Number
114755390
Date Filed
June 27, 2006
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077500370
Date of Patent
July 6, 2010
0Patent Application Number
114755390
Date Filed
June 27, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07750037 Antidepressant
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07750037
Date of patent
July 6, 2010
Patent application number
11475539
Date Filed
June 27, 2006
Patent primary examiner
Find more entities like US Patent 7750037 Antidepressant
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.